SOMERSET, N.J. (May 20, 2019) -- Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has completed the $1.2 billion acquisition of Paragon Bioservices,…
Read More
© 2024 Leonard Green & Partners, L.P. All rights reserved.